Global Renal Cell Cacinoma Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Renal Cell Cacinoma Drugs Market Overview

• 1.1 Product Overview and Scope of Renal Cell Cacinoma Drugs
• 1.2 Renal Cell Cacinoma Drugs Segment by Type
  • 1.2.1 Global Renal Cell Cacinoma Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Sutent(Sunitinib)
  • 1.2.3 Nexavar(Sorafenib)
  • 1.2.4 Votrient(Pazopanib)
  • 1.2.5 Avastin(Bevacizumab)
  • 1.2.6 Afinitor(Everolimus)
  • 1.2.7 Inlyta(Axitinib)
  • 1.2.8 Torisel(Temsirolimus)
  • 1.2.9 Proleukin(Aldesleukin)
• 1.3 Renal Cell Cacinoma Drugs Segment by Application
  • 1.3.1 Renal Cell Cacinoma Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Mucinous Tubular and Spindle Cell Carcinoma (MTSCC)
  • 1.3.3 Multilocular Cystic Clear Cell Renal Cell Carcinoma
  • 1.3.4 Tubulocystic Renal Cell Carcinoma
  • 1.3.5 Thyroid-Like Follicular Renal Cell Carcinoma
  • 1.3.6 Others
• 1.3 Global Renal Cell Cacinoma Drugs Market by Region
  • 1.3.1 Global Renal Cell Cacinoma Drugs Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Renal Cell Cacinoma Drugs Market Size
  • 1.4.1 Global Renal Cell Cacinoma Drugs Revenue (2014-2025)
  • 1.4.2 Global Renal Cell Cacinoma Drugs Production (2014-2025)

2 Global Renal Cell Cacinoma Drugs Market Competition by Manufacturers

• 2.1 Global Renal Cell Cacinoma Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Renal Cell Cacinoma Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Renal Cell Cacinoma Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Renal Cell Cacinoma Drugs Production Sites, Area Served, Product Types
• 2.5 Renal Cell Cacinoma Drugs Market Competitive Situation and Trends
  • 2.5.1 Renal Cell Cacinoma Drugs Market Concentration Rate
  • 2.5.2 Renal Cell Cacinoma Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Renal Cell Cacinoma Drugs Production Market Share by Regions

• 3.1 Global Renal Cell Cacinoma Drugs Production Market Share by Regions
• 3.2 Global Renal Cell Cacinoma Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Renal Cell Cacinoma Drugs Production
  • 3.4.1 North America Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Renal Cell Cacinoma Drugs Production
  • 3.5.1 Europe Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Renal Cell Cacinoma Drugs Production (2014-2019)
  • 3.6.1 China Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Renal Cell Cacinoma Drugs Production (2014-2019)
  • 3.7.1 Japan Renal Cell Cacinoma Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Renal Cell Cacinoma Drugs Consumption by Regions

• 4.1 Global Renal Cell Cacinoma Drugs Consumption by Regions
• 4.2 North America Renal Cell Cacinoma Drugs Consumption (2014-2019)
• 4.3 Europe Renal Cell Cacinoma Drugs Consumption (2014-2019)
• 4.4 China Renal Cell Cacinoma Drugs Consumption (2014-2019)
• 4.5 Japan Renal Cell Cacinoma Drugs Consumption (2014-2019)

5 Global Renal Cell Cacinoma Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Renal Cell Cacinoma Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Renal Cell Cacinoma Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Renal Cell Cacinoma Drugs Price by Type (2014-2019)
• 5.4 Global Renal Cell Cacinoma Drugs Production Growth by Type (2014-2019)

6 Global Renal Cell Cacinoma Drugs Market Analysis by Applications

• 6.1 Global Renal Cell Cacinoma Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Renal Cell Cacinoma Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Renal Cell Cacinoma Drugs Business

• 7.1 Merck & Co., Inc.
  • 7.1.1 Merck & Co., Inc. Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.1.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.1.3 Merck & Co., Inc. Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Exelixis Inc
  • 7.2.1 Exelixis Inc Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.2.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.2.3 Exelixis Inc Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Argus Therapeutics, Inc.
  • 7.3.1 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.3.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.3.3 Argus Therapeutics, Inc. Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Bristol-Myers Squibb
  • 7.4.1 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.4.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.4.3 Bristol-Myers Squibb Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Genentech
  • 7.5.1 Genentech Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.5.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.5.3 Genentech Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Immatics Biotechnologies
  • 7.6.1 Immatics Biotechnologies Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.6.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.6.3 Immatics Biotechnologies Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 AVEO Oncology
  • 7.7.1 AVEO Oncology Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.7.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.7.3 AVEO Oncology Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Eisai
  • 7.8.1 Eisai Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.8.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.8.3 Eisai Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Acceleron
  • 7.9.1 Acceleron Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.9.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.9.3 Acceleron Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Rexahn Pharmaceuticals
  • 7.10.1 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production Sites and Area Served
  • 7.10.2 Renal Cell Cacinoma Drugs Product Introduction, Application and Specification
  • 7.10.3 Rexahn Pharmaceuticals Renal Cell Cacinoma Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Bionomics
• 7.12 Cerulean Pharma Inc
• 7.13 Celldex Therapeutics
• 7.14 TVAX Biomedical
• 7.15 TRACON Pharmaceuticals

8 Renal Cell Cacinoma Drugs Manufacturing Cost Analysis

• 8.1 Renal Cell Cacinoma Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Renal Cell Cacinoma Drugs
• 8.4 Renal Cell Cacinoma Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Renal Cell Cacinoma Drugs Distributors List
• 9.3 Renal Cell Cacinoma Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Renal Cell Cacinoma Drugs Market Forecast

• 11.1 Global Renal Cell Cacinoma Drugs Production, Revenue Forecast
  • 11.1.1 Global Renal Cell Cacinoma Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Renal Cell Cacinoma Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Renal Cell Cacinoma Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Renal Cell Cacinoma Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Renal Cell Cacinoma Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Renal Cell Cacinoma Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Renal Cell Cacinoma Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Renal Cell Cacinoma Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Renal Cell Cacinoma Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Renal Cell Cacinoma Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Renal Cell Cacinoma Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Renal Cell Cacinoma Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Renal Cell Cacinoma Drugs Consumption Forecast (2019-2025)
• 11.4 Global Renal Cell Cacinoma Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Renal Cell Cacinoma Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List